These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
695 related articles for article (PubMed ID: 36615885)
21. The effect of microbiome therapy on COVID-19-induced gut dysbiosis: A narrative and systematic review. Yousef M; Rob M; Varghese S; Rao S; Zamir F; Paul P; Chaari A Life Sci; 2024 Apr; 342():122535. PubMed ID: 38408636 [TBL] [Abstract][Full Text] [Related]
22. Understanding the gut microbiota in cancer cachexia. Rocha IM; Fonseca DC; Torrinhas RSM; Waitzberg DL Curr Opin Clin Nutr Metab Care; 2023 Sep; 26(5):482-489. PubMed ID: 37389459 [TBL] [Abstract][Full Text] [Related]
23. The Effects of Probiotics, Prebiotics and Synbiotics in Non-Alcoholic Fat Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH): A Systematic Review. Carpi RZ; Barbalho SM; Sloan KP; Laurindo LF; Gonzaga HF; Grippa PC; Zutin TLM; Girio RJS; Repetti CSF; Detregiachi CRP; Bueno PCS; Mazuqueli Pereira ESB; Goulart RA; Haber JFDS Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955942 [TBL] [Abstract][Full Text] [Related]
24. Review article: can bugs be drugs? The potential of probiotics and prebiotics as treatment for non-alcoholic fatty liver disease. Koopman N; Molinaro A; Nieuwdorp M; Holleboom AG Aliment Pharmacol Ther; 2019 Sep; 50(6):628-639. PubMed ID: 31373710 [TBL] [Abstract][Full Text] [Related]
25. Modulating Gut Microbiota: An Emerging Approach in the Prevention and Treatment of Multiple Sclerosis. Ullah H; Tovchiga O; Daglia M; Khan H Curr Neuropharmacol; 2021; 19(11):1966-1983. PubMed ID: 33596808 [TBL] [Abstract][Full Text] [Related]
26. A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders. Sorboni SG; Moghaddam HS; Jafarzadeh-Esfehani R; Soleimanpour S Clin Microbiol Rev; 2022 Jan; 35(1):e0033820. PubMed ID: 34985325 [TBL] [Abstract][Full Text] [Related]
27. Gut microbiome modulation by probiotics, prebiotics, synbiotics and postbiotics: a novel strategy in food allergy prevention and treatment. Shi J; Wang Y; Cheng L; Wang J; Raghavan V Crit Rev Food Sci Nutr; 2024; 64(17):5984-6000. PubMed ID: 36576159 [TBL] [Abstract][Full Text] [Related]
28. Understanding the gut microbiota and sarcopenia: a systematic review. Liu C; Cheung WH; Li J; Chow SK; Yu J; Wong SH; Ip M; Sung JJY; Wong RMY J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1393-1407. PubMed ID: 34523250 [TBL] [Abstract][Full Text] [Related]
29. Gut microbiota-derived metabolites as key actors in type 2 diabetes mellitus. Du L; Li Q; Yi H; Kuang T; Tang Y; Fan G Biomed Pharmacother; 2022 May; 149():112839. PubMed ID: 35325852 [TBL] [Abstract][Full Text] [Related]
30. Therapeutic Methods for Gut Microbiota Modification in Lipopolysaccharide-Associated Encephalopathy. Li S; Guo H; Xu X; Hua R; Zhao Q; Li J; Lv J; Li J Shock; 2021 Nov; 56(5):824-831. PubMed ID: 33595259 [TBL] [Abstract][Full Text] [Related]
31. Dietary Component-Induced Inflammation and Its Amelioration by Prebiotics, Probiotics, and Synbiotics. Bilal M; Ashraf S; Zhao X Front Nutr; 2022; 9():931458. PubMed ID: 35938108 [TBL] [Abstract][Full Text] [Related]
32. Prebiotics, probiotics, synbiotics and postbiotics to adolescents in metabolic syndrome. Luzzi A; Briata IM; Di Napoli I; Giugliano S; Di Sabatino A; Rescigno M; Cena H Clin Nutr; 2024 Jun; 43(6):1433-1446. PubMed ID: 38704983 [TBL] [Abstract][Full Text] [Related]
33. Over-feeding the gut microbiome: A scoping review on health implications and therapeutic perspectives. Barone M; D'Amico F; Fabbrini M; Rampelli S; Brigidi P; Turroni S World J Gastroenterol; 2021 Nov; 27(41):7041-7064. PubMed ID: 34887627 [TBL] [Abstract][Full Text] [Related]
34. Dietary Fat Modulation of Gut Microbiota and Impact on Regulatory Pathways Controlling Food Intake. Hamamah S; Amin A; Al-Kassir AL; Chuang J; Covasa M Nutrients; 2023 Jul; 15(15):. PubMed ID: 37571301 [TBL] [Abstract][Full Text] [Related]
35. Does gut microbiota affect the success of weight loss? Evidence and speculation. Moszak M; Pelczyńska M; Wesołek A; Stenclik D; Bogdański P Nutrition; 2023 Dec; 116():112111. PubMed ID: 37562188 [TBL] [Abstract][Full Text] [Related]
36. Gut microbiota and old age: Modulating factors and interventions for healthy longevity. Coman V; Vodnar DC Exp Gerontol; 2020 Nov; 141():111095. PubMed ID: 32979504 [TBL] [Abstract][Full Text] [Related]
37. The potential preventive effect of probiotics, prebiotics, and synbiotics on cardiovascular risk factors through modulation of gut microbiota: A review. Ghanbari F; Hasani S; Aghili ZS; Asgary S Food Sci Nutr; 2024 Jul; 12(7):4569-4580. PubMed ID: 39055176 [TBL] [Abstract][Full Text] [Related]
38. Modulating the gut microbiota by probiotics, prebiotics, postbiotics, and fecal microbiota transplantation: An emerging trend in cancer patient care. Ciernikova S; Sevcikova A; Drgona L; Mego M Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):188990. PubMed ID: 37742728 [TBL] [Abstract][Full Text] [Related]
39. Gut Microbiota and Probiotics/Synbiotics for Modulation of Immunity in Critically Ill Patients. Shimizu K; Ojima M; Ogura H Nutrients; 2021 Jul; 13(7):. PubMed ID: 34371948 [TBL] [Abstract][Full Text] [Related]
40. Exploring substrate-microbe interactions: a metabiotic approach toward developing targeted synbiotic compositions. Speckmann B; Ehring E; Hu J; Rodriguez Mateos A Gut Microbes; 2024; 16(1):2305716. PubMed ID: 38300741 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]